Skip to content

Receptos, Inc.

Delisted

CIK 1463729fmd_065CHQBBEDJ47WSBPHAR6D43VFManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Jun 30, 2015, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013FY2014
Research and development132344102
Total operating expenses162653117
Operating income(6)(18)(48)(112)
Interest expense––01
Interest and investment income0000
Other non-operating income (expense)–(0)(0)0
Income tax expense–000
Net income(6)(18)(48)(115)
Net income to common shareholders(6)(18)(50)(115)